Novamind (NM.C) – Investor Roundtable

Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.

Today, our focus is on Novamind (NM.C), a company attempting to capitalize on the psychedelics market boom. Is it real value or a hallucinogenic nightmare?



The post Novamind (NM.C) – Investor Roundtable appeared first on Equity.Guru.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.